CrossRef Crocin II alleviates metabolic dysfunction-associated steatotic liver disease by enhancing autophagic degradation of ANGPTL8 Rongtian Zhang, Kongdong Li, Ziting Zhao, Xintong Jiang, Rumeng Zhang, Chang Liu, Wenxiang Zhang, Siyu Chen Targetome .2026;[Epub] CrossRef Endocrine disruptors reprogram hepatic metabolic and immune gene networks to promote hepatocellular carcinoma Yanggang Hong, Yi Wang, Qingyu Chen, Yirong Wang npj Gut and Liver .2026;[Epub] CrossRef Exercise-responsive skeletal muscle genes mechanistically linked to metabolic dysfunction-associated steatotic liver disease Jia-Hui Zhang, Kang Chen, Xiao-Min Zhu, Huan Zhou, Jia-Mi Jiang, Yu-Qing Zou, Ke-Rong Liu, Le Zhang, Yun Li World Journal of Gastroenterology .2026;[Epub] CrossRef Multimodal assessment of hepatic steatosis heterogeneity: segmental MRI-PDFF and ultrasound attenuation coefficient measurement M.M
Whats the difference between the brand-name and alternative GLP-1 options
Lozenges: Like oral drops, they contain the same active ingredients as the brand name GLP-1s but are produced by compounding pharmacies and are not approved by the FDA
But its off-label misuse reflects a deeper societal issue: the commodification of thinness and the medicalization of appearance
Beyond the medication, consistency in your diet and exercise habits is where the real magic happens
Thank you Crai-Dean for your professionalism, and heart felt welcomes